Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Bazarbachi A, Boumendil A, Finel H, Mohty M, et al. Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. Cancer 2018 Oct 23. doi: 10.1002/cncr.31755.
PMID: 30351488


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016